These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 14700450)

  • 1. Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.
    DeVane CL
    J Clin Psychiatry; 2003; 64 Suppl 18():14-9. PubMed ID: 14700450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving antidepressant adherence.
    Nemeroff CB
    J Clin Psychiatry; 2003; 64 Suppl 18():25-30. PubMed ID: 14700452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of venlafaxine in rational antidepressant therapy.
    Feighner JP
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():62-8; discussion 69-70, 98-100. PubMed ID: 7961545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of depression with different formulations of venlafaxine: a comparative analysis.
    Olver JS; Burrows GD; Norman TR
    Hum Psychopharmacol; 2004 Jan; 19(1):9-16. PubMed ID: 14716706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential pharmacology of newer antidepressants.
    DeVane CL
    J Clin Psychiatry; 1998; 59 Suppl 20():85-93. PubMed ID: 9881541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.
    Kennedy SH; McCann SM; Masellis M; McIntyre RS; Raskin J; McKay G; Baker GB
    J Clin Psychiatry; 2002 Mar; 63(3):181-6. PubMed ID: 11926715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion: a review of its use in the management of major depressive disorder.
    Dhillon S; Yang LP; Curran MP
    Drugs; 2008; 68(5):653-89. PubMed ID: 18370448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of paroxetine.
    Boyer WF; Feighner JP
    J Clin Psychiatry; 1992 Feb; 53 Suppl():3-6. PubMed ID: 1531819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant drug selection: criteria and options.
    Preskorn SH
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():6-22; discussion 23-4, 98-100. PubMed ID: 7961544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic optimisation of therapy with newer antidepressants.
    Goodnick PJ
    Clin Pharmacokinet; 1994 Oct; 27(4):307-30. PubMed ID: 7834966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New formulations of existing antidepressants: advantages in the management of depression.
    Norman TR; Olver JS
    CNS Drugs; 2004; 18(8):505-20. PubMed ID: 15182220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical pharmacology and use of paroxetine, a new selective serotonin reuptake inhibitor.
    Nemeroff CB
    Pharmacotherapy; 1994; 14(2):127-38. PubMed ID: 8197030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic considerations of antidepressant use in the elderly.
    DeVane CL; Pollock BG
    J Clin Psychiatry; 1999; 60 Suppl 20():38-44. PubMed ID: 10513858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the selective serotonin reuptake inhibitors.
    DeVane CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():13-20. PubMed ID: 1531816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani].
    Gaillard R
    Encephale; 2009 Oct; 35(5):499-504. PubMed ID: 19853726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of controlled-release paroxetine.
    Golden RN
    Psychopharmacol Bull; 2003; 37 Suppl 1():176-86. PubMed ID: 14566210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion sustained release: a therapeutic overview.
    Davidson JR; Connor KM
    J Clin Psychiatry; 1998; 59 Suppl 4():25-31. PubMed ID: 9554318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion sustained release: side effect profile.
    Settle EC
    J Clin Psychiatry; 1998; 59 Suppl 4():32-6. PubMed ID: 9554319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of anxiety disorders with venlafaxine XR.
    Thase ME
    Expert Rev Neurother; 2006 Mar; 6(3):269-82. PubMed ID: 16533131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.